Phenotypic Selection with an Intrabody Library Reveals an Anti-apoptotic Function of PKM2 Requiring Mitofusin-1

Overview

Journal PLoS Biol

Specialty Biology

Date 2019 Jun 11

PMID 31181072

Citations 8

Authors

Tong Liu

Tomomi Kuwana

Hongkai Zhang

Matthew G Vander Heiden

Richard A Lerner

Donald D Newmeyer

Affiliations

Soon will be listed here.

Abstract

Bcl-2 family proteins control a decisive apoptotic event: mitochondrial outer membrane permeabilization (MOMP). To discover MOMP-regulating proteins, we expressed a library of intracellular single-chain variable fragments (scFvs) ("intrabodies") and selected for those rescuing cells from apoptosis induced by BimS (the short isoform of Bim). One anti-apoptotic intrabody, intrabody 5 (IB5), recognized pyruvate kinase M2 (PKM2), which is expressed in cancer cells. PKM2 deletion ablated this clonogenic rescue; thus, IB5 activated a latent cytoprotective function of PKM2. This resulted not from pyruvate kinase activity per se but rather from the formation of an active tetrameric conformation of PKM2. A stably tetrameric PKM2 mutant, K422R, promoted cell survival even in the absence of IB5, and IB5 further increased survival. Mitochondria isolated from IB5-expressing cells were relatively resistant to MOMP in vitro. In cells, IB5 expression up-regulated Mitofusin-1 (Mfn1) and increased mitochondrial length. Importantly, Mfn1 deficiency abrogated IB5's cytoprotective effect. PKM2's anti-apoptotic function could help explain its preferential expression in human cancer.

Citing Articles

Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma.

Wang B, Qi F, Chen P, Qian L, Su H, Wang Y Int J Biol Sci. 2024; 20(5):1634-1651.

PMID: 38481819 PMC: 10929192. DOI: 10.7150/ijbs.92211.

From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases.

Zhang L, Miao M, Xu X, Bai M, Wu M, Zhang A Kidney Dis (Basel). 2023; 9(5):342-357.

PMID: 37901706 PMC: 10601966. DOI: 10.1159/000530485.

Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury.

Xie W, He Q, Zhang Y, Xu X, Wen P, Cao H Cell Death Dis. 2023; 14(10):663.

PMID: 37816709 PMC: 10564883. DOI: 10.1038/s41419-023-06195-z.

PKM2 deficiency exacerbates gram-negative sepsis-induced cardiomyopathy via disrupting cardiac calcium homeostasis.

Ni L, Lin B, Shen M, Li C, Hu L, Fu F Cell Death Discov. 2022; 8(1):496.

PMID: 36564378 PMC: 9789059. DOI: 10.1038/s41420-022-01287-9.

Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm.

Walther J, Kirsch E, Hellwig L, Schmerbeck S, Holloway P, Buchan A Transl Stroke Res. 2022; 14(5):643-666.

PMID: 36219377 PMC: 10444697. DOI: 10.1007/s12975-022-01090-9.

References

Bollenbach T, Mesecar A, Nowak T . Role of lysine 240 in the mechanism of yeast pyruvate kinase catalysis. Biochemistry. 1999; 38(28):9137-45. DOI: 10.1021/bi990690n. View

Choudhary V, Kaddour-Djebbar I, Alaisami R, Kumar M, Bollag W . Mitofusin 1 degradation is induced by a disruptor of mitochondrial calcium homeostasis, CGP37157: a role in apoptosis in prostate cancer cells. Int J Oncol. 2014; 44(5):1767-73. DOI: 10.3892/ijo.2014.2343. View

Gillies L, Du H, Peters B, Knudson C, Newmeyer D, Kuwana T . Visual and functional demonstration of growing Bax-induced pores in mitochondrial outer membranes. Mol Biol Cell. 2014; 26(2):339-49. PMC: 4294680. DOI: 10.1091/mbc.E13-11-0638. View

Kwon O, Kang T, Kim J, Kim M, Noh S, Song K . Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level. Biochem Biophys Res Commun. 2012; 423(1):38-44. DOI: 10.1016/j.bbrc.2012.05.063. View

Chen L, Willis S, Wei A, Smith B, Fletcher J, Hinds M . Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005; 17(3):393-403. DOI: 10.1016/j.molcel.2004.12.030. View

Cheon J, Kim S, Son J, Kang Y, An J, Kwon J . Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury. Toxicol Res. 2016; 32(1):47-56. PMC: 4780241. DOI: 10.5487/TR.2016.32.1.047. View

Montero J, Sarosiek K, DeAngelo J, Maertens O, Ryan J, Ercan D . Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015; 160(5):977-989. PMC: 4391197. DOI: 10.1016/j.cell.2015.01.042. View

Leverson J, Zhang H, Chen J, Tahir S, Phillips D, Xue J . Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis. 2015; 6:e1590. PMC: 4669759. DOI: 10.1038/cddis.2014.561. View

Shi H, Li D, Zhang J, Wang Y, Yang L, Zhang H . Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Sci. 2010; 101(6):1447-53. PMC: 11158281. DOI: 10.1111/j.1349-7006.2010.01562.x. View

10.

Hitosugi T, Kang S, Vander Heiden M, Chung T, Elf S, Lythgoe K . Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal. 2009; 2(97):ra73. PMC: 2812789. DOI: 10.1126/scisignal.2000431. View

11.

Bender T, Martinou J . Where killers meet--permeabilization of the outer mitochondrial membrane during apoptosis. Cold Spring Harb Perspect Biol. 2013; 5(1):a011106. PMC: 3579396. DOI: 10.1101/cshperspect.a011106. View

12.

Zhang H, Torkamani A, Jones T, Ruiz D, Pons J, Lerner R . Phenotype-information-phenotype cycle for deconvolution of combinatorial antibody libraries selected against complex systems. Proc Natl Acad Sci U S A. 2011; 108(33):13456-61. PMC: 3158238. DOI: 10.1073/pnas.1111218108. View

13.

Kluck R, Bossy-Wetzel E, Green D, Newmeyer D . The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997; 275(5303):1132-6. DOI: 10.1126/science.275.5303.1132. View

14.

Ryu S, Choi K, Park J, Park Y, Kim S, Choi C . Mitofusin 1 inhibits an apoptosis-associated amino-terminal conformational change in Bax, but not its mitochondrial translocation, in a GTPase-dependent manner. Cancer Lett. 2012; 323(1):62-68. DOI: 10.1016/j.canlet.2012.03.038. View

15.

Morgan H, OReilly F, Wear M, ONeill J, Fothergill-Gilmore L, Hupp T . M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci U S A. 2013; 110(15):5881-6. PMC: 3625322. DOI: 10.1073/pnas.1217157110. View

16.

Iqbal M, Gupta V, Gopinath P, Mazurek S, Bamezai R . Pyruvate kinase M2 and cancer: an updated assessment. FEBS Lett. 2014; 588(16):2685-92. DOI: 10.1016/j.febslet.2014.04.011. View

17.

Luo W, Semenza G . Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget. 2011; 2(7):551-6. PMC: 3248177. DOI: 10.18632/oncotarget.299. View

18.

Czabotar P, Lessene G, Strasser A, Adams J . Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2013; 15(1):49-63. DOI: 10.1038/nrm3722. View

19.

Waterhouse N, Goldstein J, Kluck R, Newmeyer D, Green D . The (Holey) study of mitochondria in apoptosis. Methods Cell Biol. 2001; 66:365-91. DOI: 10.1016/s0091-679x(01)66017-5. View

20.

Dong T, Yan Y, Chai H, Chen S, Xiong X, Sun D . Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. Biomed Pharmacother. 2015; 69:277-84. DOI: 10.1016/j.biopha.2014.12.010. View